Insulin Resistance in Striated Muscle-specific Integrin Receptor β1-deficient Mice*
- Haihong Zong‡,
- Claire C. Bastie‡,
- Jun Xu§,
- Reinhard Fassler¶,
- Kevin P. Campbell∥,
- Irwin J. Kurland§ and
- Jeffrey E. Pessin‡1
- ‡Departments of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, §Department of Medicine, Stony Brook University, Stony Brook, New York 11794, ¶Max Planck Institute for Biochemistry, Department of Molecular Medicine, Am Klopferspitz 18, 82152 Martinsried, Germany, and ∥Howard Hughes Medical Institute, Departments of Molecular Physiology and Biophysics, Neurology, and Internal Medicine, Carver College of Medicine, The University of Iowa, Iowa City, Iowa 52242
- 1 To whom correspondence should be addressed: Dept. of Medicine, Albert Einstein College of Medicine, 1301 Morris Park Ave., Bronx, NY 10461. Tel.: 718-678-1029; Fax: 718-678-1020; E-mail: jpessin{at}aecom.yu.edu.
Abstract
Integrin receptor plays key roles in mediating both inside-out and outside-in signaling between cells and the extracellular matrix. We have observed that the tissue-specific loss of the integrin β1 subunit in striated muscle results in a near complete loss of integrin β1 subunit protein expression concomitant with a loss of talin and to a lesser extent, a reduction in F-actin content. Muscle-specific integrin β1-deficient mice had no significant difference in food intake, weight gain, fasting glucose, and insulin levels with their littermate controls. However, dynamic analysis of glucose homeostasis using euglycemichyperinsulinemic clamps demonstrated a 44 and 48% reduction of insulin-stimulated glucose infusion rate and glucose clearance, respectively. The whole body insulin resistance resulted from a specific inhibition of skeletal muscle glucose uptake and glycogen synthesis without any significant effect on the insulin suppression of hepatic glucose output or insulin-stimulated glucose uptake in adipose tissue. The reduction in skeletal muscle insulin responsiveness occurred without any change in GLUT4 protein expression levels but was associated with an impairment of the insulin-stimulated protein kinase B/Akt serine 473 phosphorylation but not threonine 308. The inhibition of insulin-stimulated serine 473 phosphorylation occurred concomitantly with a decrease in integrin-linked kinase expression but with no change in the mTOR·Rictor·LST8 complex (mTORC2). These data demonstrate an in vivo crucial role of integrin β1 signaling events in mediating cross-talk to that of insulin action.
Footnotes
-
↵2 The abbreviations used are: IRS, insulin receptor substrate; ILK, integrin-linked kinase; MCK, muscle creatine kinase; Itgβ1, integrin β1; KO, knockout; EU, euglycemic-hyperinsulinemic; PDK, phosphoinositide-dependent protein kinase; PI 3-kinase, phosphatidylinositol 3-kinase; GLUT4, glucose transporter isoform 4; GSK, glycogen synthase kinase.
-
↵* This work was supported, in whole or in part, by National Institutes of Health Grants DK55811, DK33823, and DK20541. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Received September 24, 2008.
- Revision received December 1, 2008.
- The American Society for Biochemistry and Molecular Biology, Inc.











